News CSL FY net profit dips to $A3.2bn Blood products and vaccines supplier CSL has reported a six per cent fall in annual profit and is tipping a slightly better earnings performance in 2022/23. 17 Aug 2022
Health CSL says vaccine manufacture accelerated Biotech giant CSL says it has accelerated the manufacture of the AstraZeneca COVID-19 vaccine with the first doses planned for release in late March. 18 Feb 2021
Remuneration Incentives drive executive pay Business News's in-depth remuneration survey shines a light on the state's high-income earners. 02 Dec 2020
